Skip to Content

Itonis Inc ITNS

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ITNS is trading at a 378% premium.
Price
$0.00
Fair Value
$2.31
Uncertainty
Extreme
1-Star Price
$2.32
5-Star Price
$2.58
Economic Moat
Cspd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ITNS is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.25
Market Cap
$609,363.93
Volume/Avg
1,111 / 7.4 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Itonis Inc is a development-stage company. It operates as a holding company, which engages in the development and distribution of products to the medical and pharmaceutical industry. It is presently focused on marketing its Emesyl homeopathic anti-nausea product for retail sale. It produces and markets over-the-counter and prescription homeopathic preparations to treat both common ailments and chronic diseases.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Total Number of Employees
3

Valuation

Metric
ITNS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
ITNS
Quick Ratio
0.11
Current Ratio
0.24
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
ITNS
Return on Assets (Normalized)
−411.76%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Medical Distribution Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MCK
McKesson CorpMmkblxstMgzky$72.9 Bil
COR
Cencora IncVcpbcdzyLqhpzrj$43.1 Bil
CAH
Cardinal Health IncWlmdtdjBfsrsd$23.5 Bil
SHTDY
Sinopharm Group Co Ltd ADRBxszpd$8.7 Bil
SHTDF
Sinopharm Group Co LtdCgsxnt$8.7 Bil
SHPMF
Shanghai Pharmaceuticals Holding Co Ltd Class HPjmkh$8.6 Bil
SHPMY
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class HJdrfnn$8.5 Bil
AMFPF
Amplifon SpA Az nom Post FrazionamentoMzsytv$8.3 Bil
MAHLY
Medipal Holdings Corp ADRBptyr$3.0 Bil
MEPDF
Medipal Holdings CorpKrq$3.0 Bil

Sponsor Center